Etodolac Clinical Pharmacokinetics

  title={Etodolac Clinical Pharmacokinetics},
  author={D. Brocks and F. Jamali},
  journal={Clinical Pharmacokinetics},
  • D. Brocks, F. Jamali
  • Published 1994
  • Medicine
  • Clinical Pharmacokinetics
  • SummaryEtodolac is a chiral nonsteroidal anti-inflammatory drug (NSAID) that is marketed as the racemate. Currently, the drug is available in several countries for the treatment of arthritis and the alleviation of pain.Etodolac possesses several unique disposition features mainly due to its stereoselective pharmacokinetics. In plasma, the concentrations of the ‘inactive’ R-enantiomer are about 10-fold higher than those of the active S-enantiomer, an observation that is novel among the chiral… CONTINUE READING
    49 Citations
    Clinical Pharmacokinetics of Ibuprofen
    • N. M. Davies
    • Chemistry, Medicine
    • Clinical pharmacokinetics
    • 1998
    • 204
    Clinical Pharmacokinetics of Naproxen
    • 91
    Clinical Pharmacokinetics of Tiaprofenic Acid and its Enantiomers
    • N. M. Davies
    • Chemistry, Medicine
    • Clinical pharmacokinetics
    • 1996
    • 20
    Chiral Bioequivalence
    • 12
    Pharmacokinetic modeling and simulation of etodolac following single oral administration in dogs
    • I. Baek
    • Medicine
    • Xenobiotica; the fate of foreign compounds in biological systems
    • 2019
    • 1
    • Highly Influenced
    Stereoselective Pharmacokinetics and Chiral Inversion of Ibuprofen in Adjuvant-induced Arthritic Rats
    • 9
    • PDF
    Pharmacokinetic and Pharmacodynamic Action of Etodolac in Patients after Oral Surgery
    • 23
    Safety profiles of leading nonsteroidal anti-inflammatory drugs.
    • 27


    Clinical Pharmacokinetics of Ketorolac Tromethamine
    • 106
    Pharmacokinetics of the enantiomers of tiaprofenic acid in humans.
    • 55
    The dispositional enantioselectivity of indobufen in man.
    • 12
    Stereoselective Disposition of Etodolac Enantiomers in Synovial Fluid
    • 32
    Bioavailability studies with etodolac in dogs and man.
    • 26
    Stereoselective pharmacokinetics and inversion of suprofen enantiomers in humans.
    • 17